VarCov Co’s Day One Biopharmaceuticals DAWN Stock Holding History

VarCov Co’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,016	Closed	-$261K	–	439
2025 Q4	$261K	Buy	+28,016	New	+$234K	0.1%	334

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

VarCov Co's DAWN Position: Q1 2026 in Review

VarCov Co sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 28,016 shares — an estimated $261K sold.

VarCov Co first reported a position in DAWN in Q4 2025 and held it in 1 quarter. The position peaked at $261K in Q4 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

VarCov Co reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
VarCov Co sold 28,016 Day One Biopharmaceuticals shares in Q1 2026, an estimated $261K.
VarCov Co first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 1 quarter.
VarCov Co's Day One Biopharmaceuticals position peaked at $261K in Q4 2025.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.